Skip to main content
RVTY
NYSE Industrial Applications And Services

Revvity Beats Q3, Raises FY2026 Guidance to $5.40-$5.45 Pro Forma Adjusted EPS

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$167
Mkt Cap
$16.916B
52W Low
$81.22
52W High
$169.06
52W Position info
106% above low
Off High info
1.2% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

RVTY has more than doubled off its 52-week low of $81.22.

Summary

Revvity beat Q3 on revenue and adjusted EPS and raised FY2026 pro forma adjusted EPS guidance to $5.40-$5.45, while filing the first pro forma financials for its up-to-$200M China IDX divestiture.


Key Events · Earnings and Guidance · RVTY

  • Q3 Beat With Margin Expansion

    Revenue of $729M vs $699M a year ago; adjusted EPS of $1.38 vs $1.18. Adjusted operating margin rose to 28.7% from 26.1%.

  • FY2026 Guidance Raised

    Pro forma revenue of approximately $2.86 billion, ~5% pro forma organic growth, and pro forma adjusted EPS of $5.40-$5.45.

  • China IDX Pro Forma Disclosed

    Up to $200M sale signed July 31, 2026, expected to close by end of 2027; pro forma statements include a $55M loss on probable disposition and remove ~$62M of nine-month revenue.

  • Segment Momentum

    Life Sciences revenue $380M vs $343M, pro forma organic +9%; Diagnostics $349M vs $356M, pro forma organic +5%.


Analysis · RVTY · Industrial Applications And Services

A clean beat paired with a raised full-year guide is the combination that reprices a large-cap medtech/health-science name, and that is what Revvity delivered. Third-quarter revenue of $729M rose from $699M a year ago, adjusted EPS of $1.38 came in well above $1.18, and adjusted operating margin expanded to 28.7% from 26.1% — margin expansion, not just top-line growth, drove the beat. Management now guides FY2026 pro forma revenue of roughly $2.86 billion, ~5% pro forma organic growth and pro forma adjusted EPS of $5.40-$5.45. The filing also supplies the first pro forma financials for the China IDX divestiture (up to $200M, signed July 31, 2026, expected to close by end of 2027), including a $55M loss on probable disposition, so investors can now model the remaining business. With the stock near its 52-week high, the risk is that expectations were already elevated; the raised guide is the offset.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 45% of the 1400 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RVTY was trading at $167.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $16.9B. The 52-week trading range was $81.22 to $169.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RVTY - Latest Insights

RVTY
Nov 03, 2026, 6:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $157.77
Real-time Price: $155.11 info
Change: -$2.66 (-2%) info
Market Cap: $17.308B info
RVTY
Sep 09, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $126.00
Real-time Price: $155.11 info
Change: +$29.11 (+23%) info
Market Cap: $17.308B info
RVTY
Aug 11, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $115.73
Real-time Price: $155.11 info
Change: +$39.38 (+34%) info
Market Cap: $17.308B info
RVTY
Aug 04, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $155.11 info
Change: +$40.11 (+35%) info
Market Cap: $17.308B info
RVTY
Aug 04, 2026, 6:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $155.11 info
Change: +$40.11 (+35%) info
Market Cap: $17.308B info